Inventor · disambiguated record
John Simard
Also filed as: SIMARD JOHN · SIMARD JOHN J · SIMARD JOHN J L
44 granted patents·54 pending applications·1,521 citations·filing 2000–2024
98Inventor score
Top patents by PatentIndex Score
98 records- 0198US8034337B2Interleukin-1α antibodiesXBIOTECH INC·Filed 2009·Granted Oct 11, 2011·1k cites·1 claims
- 0297US6861234B1Method of epitope discoveryMANNKIND CORP·Filed 2000·Granted Mar 1, 2005·111 cites·19 claims
- 0396US9486523B2Compositions and methods for treating and preventing Staphylococcus aureus infectionsXBIOTECH INC·Filed 2016·Granted Nov 8, 2016·17 cites·8 claims
- 0496US7364729B2Method of inducing a CTL responseMANNKIND CORP·Filed 2005·Granted Apr 29, 2008·28 cites·16 claims
- 0595US9416172B2Compositions and methods for treating and preventing Staphylococcus aureus infectionsXBIOTECH INC·Filed 2015·Granted Aug 16, 2016·16 cites·8 claims
- 0695US6977074B2Method of inducing a CTL responseMANNKIND CORP·Filed 2001·Granted Dec 20, 2005·89 cites·32 claims
- 0794US10899833B2Human antibody specific for interleukin-1 alphaJANSSEN BIOTECH INC·Filed 2017·Granted Jan 26, 2021·4 cites·12 claims
- 0894US9840558B2Human antibody specific for interleukin-1alphaXBIOTECH INC·Filed 2015·Granted Dec 12, 2017·9 cites·5 claims
- 0994US8388956B2Interleukin-1 alpha antibodies and methods of useSIMARD JOHN·Filed 2011·Granted Mar 5, 2013·14 cites·1 claims
- 1093US8388969B2Interleukin-1 alpha antibodies and methods of useSIMARD JOHN·Filed 2011·Granted Mar 5, 2013·14 cites·1 claims
- 1192US11370831B2Compositions and methods for treating and preventing Staphylococcus aureus infectionsXBIOTECH INC·Filed 2020·Granted Jun 28, 2022·2 cites·2 claims
- 1292US9783598B2Compositions and methods for treating and preventing Staphylococcus aureus infectionsXBIOTECH INC·Filed 2016·Granted Oct 10, 2017·7 cites·10 claims
- 1391US8784817B2Method for killing IL-1 alpha expressing cellsXBIOTECH INC·Filed 2013·Granted Jul 22, 2014·8 cites·2 claims
- 1491US8679489B2Inhibiting cell migrationXBIOTECH INC·Filed 2013·Granted Mar 25, 2014·8 cites·2 claims
- 1591US8372393B2Method of inducing a CTL responseMANNKIND CORP·Filed 2006·Granted Feb 12, 2013·8 cites·19 claims
- 1691US8252916B2Expression vectors encoding epitopes of target-associated antigens and methods for their designSIMARD JOHN J L·Filed 2004·Granted Aug 28, 2012·44 cites·39 claims
- 1790US10214581B2Compositions and methods for treating and preventing Staphylococcus aureus infectionsXBIOTECH INC·Filed 2017·Granted Feb 26, 2019·5 cites·10 claims
- 1890US8242074B2Modulation of the amount or function of pathogenic CD14+CD16+ monocytesSIMARD JOHN·Filed 2009·Granted Aug 14, 2012·13 cites·14 claims
- 1990US2024034781A1Human antibody specific for interleukin-1alphaJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2089US10202449B2Cachexia treatmentXBIOTECH INC·Filed 2017·Granted Feb 12, 2019·6 cites·3 claims
- 2189US7252824B2Anti-neovasculature preparations for cancerMANNKIND CORP·Filed 2002·Granted Aug 7, 2007·16 cites·31 claims
- 2289US7232682B2Expression vectors encoding epitopes of target-associated antigens and methods for their designMANNKIND CORP·Filed 2004·Granted Jun 19, 2007·26 cites·24 claims
- 2387US10577410B2Compositions and methods for treating and preventing Staphylococcus aureus infectionsXBIOTECH INC·Filed 2019·Granted Mar 3, 2020·3 cites·11 claims
- 2487US9181338B2Human antibody specific for IL-1alphaXBIOTECH INC·Filed 2014·Granted Nov 10, 2015·4 cites·2 claims
- 2585US8546331B2Modulation of pathogenic CD14+/CD16+ monocytesSIMARD JOHN·Filed 2012·Granted Oct 1, 2013·7 cites·14 claims
- 2685US2025051436A1Arthritis TreatmentXBIOTECH INC·Filed 2024·Application pending·0 cites
- 2784US11390672B2Arthritis treatmentJANSSEN BIOTECH INC·Filed 2019·Granted Jul 19, 2022·1 cites·7 claims
- 2884US8956831B2Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1αXBIOTECH INC·Filed 2014·Granted Feb 17, 2015·3 cites·7 claims
- 2983US11773157B2Compositions and methods for treating and preventing Staphylococcus aureus infectionsXBIOTECH INC·Filed 2022·Granted Oct 3, 2023·0 cites·7 claims
- 3083US11191831B2Treatment of psychiatric conditionsJANSSEN BIOTECH INC·Filed 2018·Granted Dec 7, 2021·1 cites·7 claims
- 3182US12116405B2Arthritis treatmentXBIOTECH INC·Filed 2022·Granted Oct 15, 2024·0 cites·9 claims
- 3280US9988447B2Treatment of diabetesXBIOTECH INC·Filed 2016·Granted Jun 5, 2018·1 cites·8 claims
- 3380US9902769B2Treatment of dermatological pathologiesXBIOTECH INC·Filed 2016·Granted Feb 27, 2018·1 cites·6 claims
- 3480US8962814B2Interleukin-1α antibodies and methods of useSIMARD JOHN·Filed 2011·Granted Feb 24, 2015·2 cites·2 claims
- 3579US10294296B2Treatment for neoplastic diseasesSIMARD JOHN·Filed 2011·Granted May 21, 2019·3 cites·2 claims
- 3679US9809649B2Cachexia treatmentXBIOTECH INC·Filed 2012·Granted Nov 7, 2017·3 cites·14 claims
- 3779US2023382989A1Treatment for neoplastic diseasesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 3878US2021171623A1Human antibody specific for interleukin-1alphaJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 3976US8187817B2Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodiesSIMARD JOHN·Filed 2006·Granted May 29, 2012·4 cites·14 claims
- 4075US9545441B2Treatment of diabetesXBIOTECH INC·Filed 2013·Granted Jan 17, 2017·1 cites·9 claims
- 4175US8637305B2Expression vectors encoding epitopes of target-associated antigens and methods for their designSIMARD JOHN J L·Filed 2002·Granted Jan 28, 2014·5 cites·4 claims
- 4275US2022062413A1Treatment of psychiatric conditionsJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 4375US2024010711A1Compositions and methods for treating and preventing staphylococcus aureus infectionsXBIOTECH INC·Filed 2023·Application pending·0 cites
- 4474US2020071388A1Immunoglobulin Variable Region LibrariesXBIOTECH INC·Filed 2019·Application pending·0 cites
- 4573US9724409B2Treatment of inflammatory skin diseaseXBIOTECH INC·Filed 2012·Granted Aug 8, 2017·1 cites·11 claims
- 4670US2021403548A1Treating vascular disease and complications thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 4769US2009148478A1Combinations of tumor-associated antigens in compositions for various types of cancersMANNKIND CORP·Filed 2008·Application pending·0 cites
- 4868US11932688B2Treatment for neoplastic diseasesJANSSEN BIOTECH INC·Filed 2018·Granted Mar 19, 2024·0 cites·12 claims
- 4968US9670483B2Immunoglobulin variable region librariesXBIOTECH INC·Filed 2016·Granted Jun 6, 2017·0 cites·5 claims
- 5066US8865175B2Increasing anti-IL-1α antibodies in a subjectSIMARD JOHN·Filed 2012·Granted Oct 21, 2014·1 cites·2 claims
Showing the top 50 of 98 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Simard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →